0001415889-18-001446.txt : 20181001
0001415889-18-001446.hdr.sgml : 20181001
20181001200320
ACCESSION NUMBER: 0001415889-18-001446
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180928
FILED AS OF DATE: 20181001
DATE AS OF CHANGE: 20181001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BORKOWSKI EDWARD
CENTRAL INDEX KEY: 0001197542
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37853
FILM NUMBER: 181098968
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
STREET 2: SUITE 400
CITY: CANONSBURG
STATE: PA
ZIP: 15317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AzurRx BioPharma, Inc.
CENTRAL INDEX KEY: 0001604191
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
BUSINESS PHONE: 646-699-7855
MAIL ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
FORMER COMPANY:
FORMER CONFORMED NAME: BioPharma d'Azur, Inc.
DATE OF NAME CHANGE: 20140331
4
1
form4-10012018_051005.xml
X0306
4
2018-09-28
0001604191
AzurRx BioPharma, Inc.
AZRX
0001197542
BORKOWSKI EDWARD
SUITE 304
BROOKLYN
NY
11226
true
false
false
false
Common Stock
2018-09-28
4
A
0
7500
2.57
A
341626
D
Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2018.
/s/ Maged Shenouda, Attorney-in-Fact
2018-10-01